These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6313412)
1. ConA-mediated binding and uptake of purified alpha-galactosidase A in Fabry fibroblasts. Hasholt L; Sørensen SA Exp Cell Res; 1983 Oct; 148(2):405-11. PubMed ID: 6313412 [TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies. Hasholt L; Wandall A; Sørensen SA Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353 [TBL] [Abstract][Full Text] [Related]
3. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease. Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697 [TBL] [Abstract][Full Text] [Related]
4. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Mayes JS; Scheerer JB; Sifers RN; Donaldson ML Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes. Fensom AH; Benson PF; Grant AR; Jacobs L J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649 [TBL] [Abstract][Full Text] [Related]
6. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement. Sifers RN; Mayes JS; Nordquist RE Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease. Lemansky P; Bishop DF; Desnick RJ; Hasilik A; von Figura K J Biol Chem; 1987 Feb; 262(5):2062-5. PubMed ID: 3029062 [TBL] [Abstract][Full Text] [Related]
8. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies. Hasholt L; Sørensen SA Clin Chim Acta; 1984 Sep; 142(2):257-61. PubMed ID: 6094040 [No Abstract] [Full Text] [Related]
9. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote. Osada T; Kuroda Y; Ikai A Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620 [TBL] [Abstract][Full Text] [Related]
10. Concanavalin A promotes the uptake of lysosomal hydrolases by human fibroblasts. Juliano RL; Moore MR; Callahan JW; Lowden JA Biochim Biophys Acta; 1978 Nov; 513(2):285-91. PubMed ID: 102347 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells. Johnson DL; Desnick RJ Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178 [No Abstract] [Full Text] [Related]
12. Uptake of lysosomal enzymes by human fibroblasts: lack of uptake of fungal or plant glycosidases in comparison with a mammalian enzyme. Dooley KC; Applegarth DA J Inherit Metab Dis; 1980; 3(4):145-7. PubMed ID: 6787335 [TBL] [Abstract][Full Text] [Related]
13. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote. Osada T; Kuroda Y; Ikai A Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088 [TBL] [Abstract][Full Text] [Related]
14. Purification and properties of the two major isozymes of alpha-galactosidase from human placenta. Kusiak JW; Quirk JM; Brady RO J Biol Chem; 1978 Jan; 253(1):184-90. PubMed ID: 201618 [No Abstract] [Full Text] [Related]
15. Factors that influence the uptake and turnover of glucocerebrosidase and alpha-galactosidase in mammalian liver. Pentchev PG; Kusiak JW; Barranger JA; Furbish FS; Rapoport SI; Massey JM; Brady RO Adv Exp Med Biol; 1978; 101():745-52. PubMed ID: 208371 [No Abstract] [Full Text] [Related]
16. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Ishii S; Chang HH; Kawasaki K; Yasuda K; Wu HL; Garman SC; Fan JQ Biochem J; 2007 Sep; 406(2):285-95. PubMed ID: 17555407 [TBL] [Abstract][Full Text] [Related]
17. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote. Rietra PJ; Van den Bergh FA; Tager JM Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216 [TBL] [Abstract][Full Text] [Related]
18. Further characterization of two forms of N-acetyl-alpha-galactosaminidase from human liver. Schram AW; De Groot PG; Hamers MN; Brouwer-Kelder B; Donker-Koopman WE; Tager JM Biochim Biophys Acta; 1978 Aug; 525(2):410-6. PubMed ID: 210819 [No Abstract] [Full Text] [Related]
19. Residual activity of alpha-galactosidase A in Fabry's disease. Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485 [TBL] [Abstract][Full Text] [Related]
20. Lectin-mediated uptake of lysosomal hydrolases by genetically deficient human fibroblasts. Juliano RL; Moore MR; Callahan JW; Lowden JA Exp Cell Res; 1979 Apr; 120(1):63-72. PubMed ID: 108116 [No Abstract] [Full Text] [Related] [Next] [New Search]